<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>20/20 GENE SYSTEMS, INC.</title>
	<atom:link href="http://www.2020gene.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.2020gene.com</link>
	<description>utilizes novel technologies in the development of innovative, proprietary diagnostics for biodefense, cancer and autoimmune diseases.</description>
	<lastBuildDate>Mon, 10 Jun 2013 12:39:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>September 12, 2012  20/20 GeneSystems to Present Data on Biomarker Panel to Improve Efficacy of Targeted Breast Cancer Therapy</title>
		<link>http://www.2020gene.com/2020-genesystems-to-present-data-on-biomarker-panel-to-improve-efficacy-of-targeted-breast-cancer-therapy/</link>
		<comments>http://www.2020gene.com/2020-genesystems-to-present-data-on-biomarker-panel-to-improve-efficacy-of-targeted-breast-cancer-therapy/#comments</comments>
		<pubDate>Tue, 18 Sep 2012 22:21:02 +0000</pubDate>
		<dc:creator>bcohen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.2020gene.com/?p=1166</guid>
		<description><![CDATA[20/20 GeneSystems to Present Data on Biomarker Panel to Improve Efficacy of Targeted Breast Cancer Therapy Scheduled to release data at ASCO Breast Cancer Symposium; One Million Dollars Awarded by National Cancer Institute   ROCKVILLE, MD, September 12, 2012 &#8212; 20/20 GeneSystems, Inc. (www.2020gene.com) will present results this week at the Breast Cancer Symposium 2012 [...]]]></description>
		<wfw:commentRss>http://www.2020gene.com/2020-genesystems-to-present-data-on-biomarker-panel-to-improve-efficacy-of-targeted-breast-cancer-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>October 8, 2010  20/20 GeneSystems Awarded $3 million from National Cancer Institute to Develop Personalized Medicine Tests</title>
		<link>http://www.2020gene.com/october-8-2010-2020-genesystems-awarded-3-million-from-national-cancer-institute-to-develop-personalized-medicine-tests/</link>
		<comments>http://www.2020gene.com/october-8-2010-2020-genesystems-awarded-3-million-from-national-cancer-institute-to-develop-personalized-medicine-tests/#comments</comments>
		<pubDate>Mon, 08 Nov 2010 20:17:53 +0000</pubDate>
		<dc:creator>bcohen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.2020gene.com/?p=1086</guid>
		<description><![CDATA[Diagnostics using patented L-IHC technology will help oncologists select targeted treatments for kidney, breast, and other solid tumors by simultaneously profiling entire mTOR signaling pathway. ROCKVILLE, MD (Oct. 11, 2010) –20/20 GeneSystems, Inc. (&#8220;20/20&#8243; ) announced today that the company has been awarded nearly $3 million in grants from the National Cancer Institute’s (NCI) Small [...]]]></description>
		<wfw:commentRss>http://www.2020gene.com/october-8-2010-2020-genesystems-awarded-3-million-from-national-cancer-institute-to-develop-personalized-medicine-tests/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>September 14, 2010     New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine</title>
		<link>http://www.2020gene.com/september-14-2010-new-multiplex-tissue-biomarker-technology-launched-to-advance-personalized-medicine/</link>
		<comments>http://www.2020gene.com/september-14-2010-new-multiplex-tissue-biomarker-technology-launched-to-advance-personalized-medicine/#comments</comments>
		<pubDate>Tue, 14 Sep 2010 16:12:25 +0000</pubDate>
		<dc:creator>bcohen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.2020gene.com/?p=1080</guid>
		<description><![CDATA[20/20 GeneSystems’ Layered IHC permits for the first time 10+ biomarkers within intact tissue sections to be analyzed simultaneously. The technology offers a superior platform for companion diagnostics to molecularly targeted therapeutics. ARLINGTON, Va.&#8211;(BUSINESS WIRE)&#8211;20/20 GeneSystems, Inc. (“20/20” ) announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch [...]]]></description>
		<wfw:commentRss>http://www.2020gene.com/september-14-2010-new-multiplex-tissue-biomarker-technology-launched-to-advance-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>20/20 launches its new L-IHC lab services July 1, 2010 using its proprietary multilayer IHC platform for the development of new companion diagnostics.</title>
		<link>http://www.2020gene.com/761/</link>
		<comments>http://www.2020gene.com/761/#comments</comments>
		<pubDate>Mon, 28 Jun 2010 18:19:22 +0000</pubDate>
		<dc:creator>bcohen</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.2020gene.com/?p=761</guid>
		<description><![CDATA[20/20 launches its new L-IHC lab services.  Beginning July 1, 20/20 will begin using its proprietary multilayer IHC platform for the development of new companion diagnostics.  Services will be preformed in 20/20&#8242;s Rockville MD laboratory under the direction of  Michael Leibowitz Phd.  New customized studies will be developed and run for leading cancer research centers [...]]]></description>
		<wfw:commentRss>http://www.2020gene.com/761/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smiths Detection to Distribute Emergency Response Biological Screening Kits Globally</title>
		<link>http://www.2020gene.com/smiths-detection-to-distribute-emergency-response-biological-screening-kits-globally/</link>
		<comments>http://www.2020gene.com/smiths-detection-to-distribute-emergency-response-biological-screening-kits-globally/#comments</comments>
		<pubDate>Sun, 17 Jan 2010 23:46:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://beta.2020gene.com/?p=189</guid>
		<description><![CDATA[Partnership Leverages Smiths Detection’s Global Security Expertise and 20/20 BioResponse’s BioCheck® Technology to Enhance Edgewood, MD, 17 February 2010 &#8211; Smiths Detection today announces a world-wide distribution agreement with 20/20 BioResponse for its BioCheck powder screening test kits. The partnership adds a low-cost, highly-effective biological threat assessment tool to strengthen Smiths Detection’s portfolio of proven [...]]]></description>
		<wfw:commentRss>http://www.2020gene.com/smiths-detection-to-distribute-emergency-response-biological-screening-kits-globally/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
